Lincoln Pharmaceuticals informs about outcome of board meeting

16 May 2024 Evaluate
Lincoln Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held today on Thursday, May 16, 2024, have considered / approved / recommended, the followings: The Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended on March 31, 2024 along with the reports of auditors thereon. It declared that the aforesaid audit reports are with unmodified opinion. The copies of the said financial results, declaration and auditors reports are enclosed herewith. In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of audited standalone and consolidated financial results for the quarter and year ended on March 31, 2024. The audited financial results (standalone and consolidated) will be available at Company's website www.lincolnpharma.com; Recommended a dividend of 1.80 (18% per share) per equity share of face value of Rs 10 for the year ended March 31, 2024, for approval of the members at the ensuring annual general meeting (AGM) of the Company; It also enclosed financial highlights of the Company for the aforesaid quarter.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

561.65 -1.85 (-0.33%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.